Clinical trial
Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy…
NCT00464607 · IBSA Institut Biochimique SA, Industry · Completed
Key facts
| NCT number | NCT00464607 |
|---|---|
| Title | Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA |
| Official title | A Prospective, Randomized, Controlled Clinical Study on the Assessment of Tolerability and of Clinical Efficacy of MERIONAL® (hMG-IBSA) Administered Subcutaneously Versus MERIONALâ Administered Intramuscularly in Women Undergoing Controlled Ovarian Hyperstimulation (COH) in an ART Programme (IVF) |
| Lead sponsor | IBSA Institut Biochimique SA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infertility |
| Intervention type | Drug, Procedure |
| Interventions | hMG-IBSA, Ovarian stimulation |
| Enrollment | 160 |
| Start date | Dec 1, 2001 |
| Completion | Apr 1, 2005 |
| First posted | Apr 23, 2007 |
| Last update posted | Apr 23, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: